Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)

(2010) A Pardanani et al.   LEUKEMIA

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

(2010) M M Patnaik et al.   LEUKEMIA

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer

(2009) B L Ebert   LEUKEMIA

Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study

(2009) Kathy Chun et al.   LEUKEMIA RESEARCH

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era

(2008) Shernan G. Holtan et al.   AMERICAN JOURNAL OF HEMATOLOGY

Cytogenetic features in myelodysplastic syndromes

(2008) Detlef Haase   ANNALS OF HEMATOLOGY

Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes

(2008) Olga Pozdnyakova et al.   CANCER